Nanophotonic biosensors for point-of-care COVID-19 diagnostics and coronavirus surveillance

The COVID-19 pandemic has revealed the need of novel diagnostic technologies for rapid and accurate virus detection. In the European CONVAT project, a point-of-care nanophotonic biosensor is being developed for the direct, fast and specific identification of severe acute respiratory syndrome coronav...

Descripción completa

Detalles Bibliográficos
Autores: Ruiz-Vega, Gisela, Soler, María, Lechuga, Laura M.
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2021
País:España
Institución:Consejo Superior de Investigaciones Científicas (CSIC)
Repositorio:DIGITAL.CSIC. Repositorio Institucional del CSIC
OAI Identifier:oai:digital.csic.es:10261/253009
Acceso en línea:http://hdl.handle.net/10261/253009
Access Level:acceso abierto
Palabra clave:Photonic biosensors
COVID-19 diagnostics
Nanophotonics
Coronavirus detection
Descripción
Sumario:The COVID-19 pandemic has revealed the need of novel diagnostic technologies for rapid and accurate virus detection. In the European CONVAT project, a point-of-care nanophotonic biosensor is being developed for the direct, fast and specific identification of severe acute respiratory syndrome coronavirus 2 from both human patient samples and animal reservoirs. The technology will provide a quantitative detection of the viral load and it can be implemented in decentralized settings to improve the early diagnosis and clinical management of patients as well as coronavirus environmental monitoring to prevent future outbreaks.